Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Cancer Metastatic × Radiofrequency Ablation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Hepatocellular 31 Neoplasm Metastasis 17 Liver Neoplasms 14 Colorectal Neoplasms 13 Lung Neoplasms 9 Cholangiocarcinoma 9 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Pancreatic Neoplasms 6 Barrett Esophagus 6 Thyroid Nodule 5 Recurrence 5 Rectal Neoplasms 5 Carcinoma, Renal Cell 5 Thyroid Neoplasms 4 Pain 4 Neoplasms 4 Leiomyoma 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Hyperaldosteronism 2 Cancer Pain 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Agnosia 2 Adrenocortical Adenoma 2

Interventions

Vertebroplasty 1 Radiotherapy 1 Radiofrequency Ablation 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06716294 2024-12-04

ABLASPINE

National and Kapodistrian University of Athens

Bone Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡